| abstract |
The invention concerns novel heteroaryloxyethylamines of general formula (I), in which Ar represents a bicyclic heteroaryl, optionally substituted by one or several substituents Y represents the -C(O)NH- or -NHC(O)- radical; a cycloalkyl optionally substituted by one or several lower alkyl(s); or a phenyl optionally substituted by one or several substituents selected among the hydroxy, cyano, halo, trifluoromethyl, lower alkyl, lower alkoxy radicals, and the salt of these products. Said products have a high affinity for the 5-HT1A receptor. The invention further concerns the method for preparing them, pharmaceutical compositions containing them and their use as medicines, and in particular as inhibitors of gastric acid or as antiemetic. |